QPS Taiwan Awarded GLP-Laboratory Certification by DOH, Taiwan
Newark, DE
QPS, a leading GLP/GCP‑compliant contract research organization providing testing services to support preclinical and clinical research and development, announced today that QPS Taiwan, its Asian operation, has been awarded a Good Laboratory Practice (GLP)‑laboratory certification by the Department of Health (DOH), Executive Yuan, R.O.C. (Taiwan). QPS received this certification due to their exceptional track record and scientific infrastructure, including global Standard Operating Procedures (SOPs), understanding of the regulatory agency of requirement, and planning for the implementation of systems and processes within the Taiwan facility.
“QPS Taiwan has been awarded the first and only GLP-laboratory certification by DOH, Taiwan for bioanalytical services supporting preclinical and clinical research,” stated QPS Taiwan President and CEO, Vincent Yen, M.B.A. “QPS Taiwan shares the same criteria, global SOPs, laboratory procedures, equipment (API 4000 triple quadrupole mass spectrometers, Shimadzu VP-series LCs, Tomtec Quadra), laboratory operations (Rees Monitors, Watson LIMS systems), and systems and processes as QPS U.S.A. We are excited about this certification..."
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
